These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16355095)

  • 1. TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications.
    Novo G; Caplice N; Tantillo R; Bonura F; Simari R; Novo S
    Int Angiol; 2005 Dec; 24(4):366-71. PubMed ID: 16355095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor and thrombin-activatable carboxypeptidase B for prediction of early atherosclerosis in gouty arthritis.
    Uyanik MS; Pamuk GE; Pamuk ON; Tuncel SA
    Thromb Res; 2014 Aug; 134(2):526-30. PubMed ID: 24974054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
    Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
    Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
    Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
    Thromb Haemost; 1994 Jun; 71(6):707-12. PubMed ID: 7974336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
    Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemia.
    Cella G; Vettor R; Sbarai A; Rossi E; Rampin E; Macor C; Mussap M; Plebani M; Luzzatto G; Girolami A
    Semin Thromb Hemost; 1997; 23(2):129-34. PubMed ID: 9200336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A; Kotschy M; Jawien A
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.
    Leurs PB; van Oerle R; Wolffenbuttel BH; Hamulyak K
    Thromb Haemost; 1997 Mar; 77(3):472-6. PubMed ID: 9065996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK; Song KS; Park YS; Yun YS; Shim WH
    Cardiology; 2000; 93(1-2):31-6. PubMed ID: 10894904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients.
    Knottnerus IL; Winckers K; Ten Cate H; Hackeng TM; Lodder J; Rouhl RP; Staals J; Govers-Riemslag JW; Bekers O; van Oostenbrugge RJ
    Neurology; 2012 Feb; 78(7):493-8. PubMed ID: 22302552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between coagulation/anticoagulation imbalance and oxidative stress in patients with chronic obstructive pulmonary disease].
    Huang J; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Nei Ke Za Zhi; 2011 Aug; 50(8):664-7. PubMed ID: 22093558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.